Concepedia

Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study

Evangelos Briasoulis, George Fountzilas, Aristotelis Bamias, Meletios Α. Dimopoulos, N. Xiros, Gerasimos Aravantinos, E. Samantas, Haralabos P. Kalofonos, Thomas Makatsoris, N. Mylonakis,

Cancer Chemotherapy and Pharmacology · 2007 · 27 citations · 30 references

DOI

Concepts

References

30

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

, , +15

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

, , +13

The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.

Alexandra Vaisman, Maria Varchenko, Asad Umar et al. · PubMed · 1998 · 298 citations

, , +17

Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study

Thierry Conroy, B Paillot, Éric François et al. · Journal of Clinical Oncology · 2005 · 239 citations

, , +17